awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40139654-844B5682-E7E5-4AFE-BC72-997D2BACAC18
Q40139654-844B5682-E7E5-4AFE-BC72-997D2BACAC18
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40139654-844B5682-E7E5-4AFE-BC72-997D2BACAC18
Superior efficacy of Adalimumab in treating childhood refractory chronic uveitis when used as first biologic modifier drug: Adalimumab as starting anti-TNF-α therapy in childhood chronic uveitis.
P2860
Q40139654-844B5682-E7E5-4AFE-BC72-997D2BACAC18
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40139654-844B5682-E7E5-4AFE-BC72-997D2BACAC18
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d7aed628a87ae6ee179f07bcbd2a304651188285
P2860
Infliximab to treat chronic noninfectious uveitis in children: retrospective case series with long-term follow-up.